• Tutorial
  • Product Matrix
  • Validate
  • Regulatory
  • ROI
  • News
  • Blog
  • Events
  • References
  • LinkedIn Group
  • Training & Consulting
  • Contact

Rapid Micro Methods News

Our news pages will keep you informed of press releases and news articles on RMM technologies, updates from technology suppliers, reviews of recent publications and presentations, and what's changing in the world of rapid methods. You can also follow our news posts on Twitter, Facebook, LinkedIn and RSS.

Follow us on Twitter Follow us on Facebook LinkedIn RSS Feed

Please click here to submit your news

Tuesday, November 27, 2018

Two Pore Guys Receives Grant to Develop Sensitive, Low-Cost Molecular Diagnostic Tests for Tuberculosis

Two Pore Guys, Inc. (2PG) announced that the company has received a $2.8 million grant from the Bill & Melinda Gates Foundation to develop sensitive, low-cost molecular diagnostic tests for tuberculosis (TB) using its solid-state nanopore technology. The 18-month grant will fund proof-of-concept work to determine if 2PG technology could provide an easy-to-use, sensitive and low-cost point-of-care device that would be compatible with automated, wireless reporting for resource-poor settings.

TB is one of the top 10 causes of death worldwide, and the leading cause from a single infectious agent. Millions of people continue to fall sick with TB each year. WHO estimates 10 million people developed TB last year worldwide.

The WHO 2018 Global TB Report, released in September, calls for an unprecedented mobilization of national and international commitments to meet the global target of ending TB by 2030. Underdiagnosis of TB is a major challenge: only about 6.4 million of the 10 million people who contracted TB in 2017 were officially recorded by national reporting systems, leaving 3.6 million people undiagnosed or detected but not reported. Late detection of Mycobacterium tuberculosis (MTB), the infectious organism that causes TB, increases the risk of transmission, delays treatment, and burdens the healthcare system. Lack of affordable, sensitive and rapid detection of MTB is a major hurdle in low- and middle-income countries. Implementing a low-cost, sensitive and portable molecular diagnostic test is expected to save thousands of dollars per patient.

“Our point-of-care technology platform offers tremendous value to address medical testing needs in resource-limited areas,” said William Dunbar, Co-founder and interim CEO of Two Pore Guys. “We are grateful to the Bill & Melinda Gates Foundation for this support and for their enthusiasm about the promise of our technology. We hope to make a difference in the lives of millions of people around the world who need better access to affordable TB care.”

About the 2PG Technology

Unlike biological nanopores used in some DNA sequencing technologies, 2PG’s devices employ silicon nanopore chips, which are robust sensors that examine a wide range of individual analytes with high sensitivity. Additionally, 2PG workflows can support multiplexed and multi-modal assays, i.e., to test for DNA/RNA and analyte/protein from a single sample source. 2PG’s patented methods also permit genotyping, e.g., for detecting drug resistance.
Posted by RapidMicro at 11:19 AM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)
  • Click to Show All News Articles

Search for News





News Archive

  • ►  2019 (10)
    • ►  February (6)
    • ►  January (4)
  • ▼  2018 (187)
    • ►  December (9)
    • ▼  November (16)
      • Nanopore Detection of Single Flu Viruses to Contro...
      • New Chlamydia Test Delivers Results in About 30 Mi...
      • Researchers Develop Tool for Speedy Diagnosis of B...
      • Pregnancy Style Test for E. coli and Romaine Lettu...
      • Mesa Biotech Receives FDA 510(k) Clearance and CLI...
      • Indian Scientists Develop Highly Sensitive and Rap...
      • LuminUltra Concludes Acquisition Of Aqua-Tools’ Ra...
      • Two Pore Guys Receives Grant to Develop Sensitive,...
      • FluChip-8G Tested in US and China for Rapid Charac...
      • Mesa Biotech Obtains CE Mark for its Accula RSV Mo...
      • Bio-Rad Wins USDA Contract for Its Pathogen Detect...
      • FDA Authorizes Emergency Use of First Ebola Finger...
      • Cellphone Technology Developed to Detect HIV
      • FDA Approves First Drug Using the Recombinant Fact...
      • Detecting E. coli Strains Using Molecular Electron...
      • UCLA Engineers Invent Small, Inexpensive RNA Detec...
    • ►  October (15)
    • ►  September (14)
    • ►  August (18)
    • ►  July (9)
    • ►  June (24)
    • ►  May (13)
    • ►  April (15)
    • ►  March (20)
    • ►  February (19)
    • ►  January (15)
  • ►  2017 (115)
    • ►  December (9)
    • ►  November (15)
    • ►  October (10)
    • ►  September (8)
    • ►  August (17)
    • ►  July (12)
    • ►  June (5)
    • ►  May (4)
    • ►  April (11)
    • ►  March (6)
    • ►  February (12)
    • ►  January (6)
  • ►  2016 (127)
    • ►  December (12)
    • ►  November (17)
    • ►  October (11)
    • ►  August (19)
    • ►  July (7)
    • ►  June (16)
    • ►  May (13)
    • ►  April (7)
    • ►  March (8)
    • ►  February (17)
  • ►  2015 (187)
    • ►  December (12)
    • ►  November (12)
    • ►  October (17)
    • ►  September (20)
    • ►  August (10)
    • ►  July (20)
    • ►  June (7)
    • ►  May (11)
    • ►  April (19)
    • ►  March (21)
    • ►  February (23)
    • ►  January (15)
  • ►  2014 (199)
    • ►  December (22)
    • ►  November (16)
    • ►  October (28)
    • ►  September (19)
    • ►  August (11)
    • ►  July (13)
    • ►  June (11)
    • ►  May (17)
    • ►  April (13)
    • ►  March (13)
    • ►  February (19)
    • ►  January (17)
  • ►  2013 (229)
    • ►  December (14)
    • ►  November (20)
    • ►  October (15)
    • ►  September (18)
    • ►  August (8)
    • ►  July (31)
    • ►  June (21)
    • ►  May (18)
    • ►  April (22)
    • ►  March (20)
    • ►  February (15)
    • ►  January (27)
  • ►  2012 (262)
    • ►  December (17)
    • ►  November (26)
    • ►  October (18)
    • ►  September (15)
    • ►  August (22)
    • ►  July (18)
    • ►  June (29)
    • ►  May (23)
    • ►  April (26)
    • ►  March (29)
    • ►  February (20)
    • ►  January (19)
  • ►  2011 (180)
    • ►  December (19)
    • ►  November (15)
    • ►  October (23)
    • ►  September (15)
    • ►  August (20)
    • ►  July (13)
    • ►  June (24)
    • ►  May (16)
    • ►  April (10)
    • ►  March (3)
    • ►  February (14)
    • ►  January (8)
  • ►  2010 (53)
    • ►  December (7)
    • ►  November (8)
    • ►  October (9)
    • ►  September (15)
    • ►  August (3)
    • ►  July (3)
    • ►  June (8)

Popular News Articles

  • Abbott Discontinuing Current Version of Plex-ID PCR System for Smaller Platform Under Development
    Abbott is discontinuing the current version of the Plex-ID system as it prepares for market a next-generation system intended to be smaller...
  • FDA Grants CLIA Waiver Expanding the Availability of Rapid Screening Test for Syphilis
    The U.S. Food and Drug Administration today announced that it granted the first-ever waiver, under certain laboratory regulations, for a rap...
  • DNA Extraction from Samples in a Minute
    Scientists at the Agharkar Research Institute (ARI) in Pune have developed a novel technology to extract bacterial DNA in just a minute from...
  • RPS Announces CE Mark of Rapid Point-Of-Care Test to Help Detect the Body's Immune Response to Viral And Bacterial Infections
    RPS Diagnostics Inc. (RPS®) announced CE mark of its FebriDx™ test clearing the way for sales in the European Union and all countries recogn...
  • Chembio Signs Agreement With CDC Contractor to Develop a Multiplex Point-of-Care Test for Influenza Immunity
    Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that it has entered int...
  • A High-Tech Real-Time Solution for Detecting Bacteria in Water
    Water quality and safety can never be taken for granted. Every day, millions of tons of inadequately treated sewage, industrial and agricult...
  • Escherichia coli Serotype O104:H4 Quality Control Strain Now Available from Microbiologics
    Leading biomaterial manufacturer, Microbiologics, has added a new strain of Shiga-toxin producing Escherichia coli (STEC) to their line o...
  • 3M Debuts Food Safety Molecular Detection Assay for Listeria monocytogenes
    The new 3M molecular detection assay for Listeria monocytogenes is the fourth test available for the 3M molecular detection system, which ...
  • MilliporeSigma Acquires BioControl to Strengthen Position in Food Safety Testing
    MilliporeSigma today announced it has acquired BioControl Systems Inc., a global leader in food safety testing. The acquisition opens grow...
  • Devices for Detecting Pathogens in Food on the Production Line
    CIC microGUNE is developing the PREDETEC project, which aims to produce sensors capable of locating infectious agents in food, thanks to the...

Links

  • Microbiology Consultants, LLC
© Copyright 2010-2019 rapidmicromethods.com. All rights reserved. • Terms of Use • Advertise
LinkedIn  LinkedIn   Follow RapidMicro on Twitter  Twitter   Follow RapidMicro on Facebook  Facebook